[EN] METALLOENZYME INHIBITOR COMPOUNDS<br/>[FR] COMPOSÉS INHIBITEURS DE MÉTALLO-ENZYMES
申请人:VIAMET PHARMACEUTICALS INC
公开号:WO2017117393A1
公开(公告)日:2017-07-06
The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
这项即时发明描述了具有金属酶调节活性的化合物,以及治疗由这些金属酶介导的疾病、疾病或症状的方法。
Pyrimidine derivative
申请人:SUMITOMO PHARMACEUTICALS COMPANY LIMITED
公开号:US20030105323A1
公开(公告)日:2003-06-05
1. A pyrimidine derivative of the formula (1) or a salt thereof;
1
has an inhibitory activity of production of Th2 type cytokines such as IL-4, IL-5, etc., and is useful as an therapeutic agent for allergic diseases, autoimmune diseases such as systemic lupus erythemathosus, etc., and acquired immunodeficiecy syndrome (AIDS) and so on.
1. A pyrimidine derivative of the formula (1) or a salt thereof;
has an inhibitory activity of production of Th2 type cytokines such as IL-4, IL-5, etc., and is useful as an therapeutic agent for allergic diseases, autoimmune diseases such as systemic lupus erythemathosus, etc., and acquired immunodeficiecy syndrome (AIDS) and so on.